AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CATALYST PHARMACEUTICALS, INC. Director's Dealing 2022

Sep 16, 2022

31542_dirs_2022-09-16_1c41f097-5440-4221-a02d-fbf5c373e85a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2022-09-14

Reporting Person: GRANDE ALICIA (VP, Treasurer and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-14	Common Stock, par value $0.001 per share	S	50000	$15.573	Disposed	357442	Direct

Footnotes

F1: Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Ms. Grande remains an officer of the Company.

F2: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.30 to $15.75 per share.